Attached files
file | filename |
---|---|
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - CNS Pharmaceuticals, Inc. | cns_ex2301.htm |
10-K/A - AMENDED ANNUAL REPORT - CNS Pharmaceuticals, Inc. | cns_10ka1-123120.htm |
EX-31.3 - CERTIFICATION BY OFFICER - CNS Pharmaceuticals, Inc. | cns_ex3103.htm |
EXHIBIT 31.4
CERTIFICATION BY OFFICER
I, Christopher Downs, certify that:
1. | I have reviewed this Form 10-K for the year ended December 31, 2020 of CNS Pharmaceuticals, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
Date: February 16, 2021 | By: | /s/ Christopher Downs |
Christopher Downs | ||
Chief Financial Officer |